Author: Ye, Fuqiang; Han, Yifang; Zhu, Juanjuan; Li, Peng; Zhang, Qi; Lin, Yanfeng; Wang, Taiwu; Lv, Heng; Wang, Changjun; Wang, Chunhui; Zhang, Jinhai
Title: First Identification of Human Adenovirus Subtype 21a in China With MinION and Illumina Sequencers Document date: 2020_4_7
ID: 18b2foud_3
Snippet: Nanopore sequencing technology was made public by Oxford Nanopore Technologies (ONT) in 2014. When DNA or RNA module translocates through a nanopore, an ionic current will be produced from a constant voltage bias, and then a change in the ionic current can be observed (van Dijk et al., 2018) . Nucleic acid bases can then be basecalled by built-in or the third-party basecallers. When compared to the next-generation sequencing (NGS) methods, nanopo.....
Document: Nanopore sequencing technology was made public by Oxford Nanopore Technologies (ONT) in 2014. When DNA or RNA module translocates through a nanopore, an ionic current will be produced from a constant voltage bias, and then a change in the ionic current can be observed (van Dijk et al., 2018) . Nucleic acid bases can then be basecalled by built-in or the third-party basecallers. When compared to the next-generation sequencing (NGS) methods, nanopore sequencing technology has advantages such as real time, long reads, short turnaround time, and simple sample preparation procedures (van Dijk et al., 2018; Ameur et al., 2019) . In particular, the ONT platform MinION, also characterized by portability and low cost in addition to the above advantages, can well handle rapid pathogen detection in the field (McIntyre et al., 2016; Castro-Wallace et al., 2017; Johnson et al., 2017; Edwards et al., 2019) . MinION has been widely employed in pathogen identification from human clinical samples to identify Chikungunya virus, hepatitis C virus, and enterovirus Imai et al., 2018; Xu et al., 2018) . It has also played a vital role in rapid pathogen confirmation in recent epidemic outbreaks caused by Ebola virus (Quick et al., 2016) , Zika virus (Faria et al., 2017; Quick et al., 2017) , yellow fever virus (Faria et al., 2018) , and Lassa virus (Kafetzopoulou et al., 2019) , highlighting the value of MinION in microbial investigation and disease control.
Search related documents:
Co phrase search for related documents- advantage addition and real time: 1
- advantage addition and RNA dna: 1
- Chikungunya virus and clinical sample: 1
- Chikungunya virus and disease control: 1, 2, 3, 4, 5, 6, 7, 8, 9
- Chikungunya virus and Ebola virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31
- Chikungunya virus and epidemic outbreak: 1, 2, 3, 4
- Chikungunya virus and fever virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50
- Chikungunya virus and Lassa virus: 1, 2, 3, 4, 5, 6, 7, 8
- Chikungunya virus and Nucleic acid: 1, 2, 3, 4
- Chikungunya virus and pathogen detection: 1
- Chikungunya virus and pathogen identification: 1
- Chikungunya virus and real time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- Chikungunya virus and RNA dna: 1, 2, 3, 4, 5, 6, 7
- Chikungunya virus and short turnaround time: 1
- Chikungunya virus and turnaround time: 1
- Chikungunya virus and yellow fever virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- Chikungunya virus and Zika virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- clinical sample and disease control: 1, 2, 3, 4, 5, 6, 7, 8, 9
- clinical sample and Ebola virus: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date